INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 212 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $475 | +101.3% | 25,642 | +45.6% | 0.05% | +88.0% |
| Q1 2023 | $236 | -99.9% | 17,609 | -10.4% | 0.02% | 0.0% |
| Q3 2022 | $274,000 | -0.4% | 19,656 | +64.9% | 0.02% | +31.6% |
| Q1 2021 | $275,000 | +12.2% | 11,921 | +20.3% | 0.02% | -26.9% |
| Q4 2020 | $245,000 | -79.6% | 9,911 | -60.4% | 0.03% | -81.3% |
| Q2 2020 | $1,199,000 | +391.4% | 25,025 | +580.0% | 0.14% | +631.6% |
| Q3 2019 | $244,000 | -32.0% | 3,680 | +14.7% | 0.02% | -5.0% |
| Q1 2019 | $359,000 | -33.3% | 3,209 | -39.9% | 0.02% | -31.0% |
| Q4 2018 | $538,000 | +142.3% | 5,342 | +101.5% | 0.03% | +190.0% |
| Q2 2018 | $222,000 | -5.1% | 2,651 | -33.8% | 0.01% | -16.7% |
| Q4 2017 | $234,000 | -33.5% | 4,003 | +174.7% | 0.01% | -61.3% |
| Q2 2015 | $352,000 | – | 1,457 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |